Asst. Prof. MD. Şencay Yıldız Şahin

Asst. Prof. MD.

Şencay Yıldız Şahin

Liv Hospital Ulus
Internal Medicine
Single Form Doctors
Asst. Prof. MD. Şencay Yıldız Şahin

Asst. Prof. MD.

Şencay Yıldız Şahin

Liv Hospital Ulus
Internal Medicine
Single Form Doctors

Areas of Interests

  • Cholesterol
  • Blood Pressure/Hypertension
  • Upper Respiratory Tract Infection
  • Diabetes (Sugar Monitoring)
  • Thyroid Diseases
  • Fatty Liver
  • Anemia (Iron and B12 deficiency)
 
Education:
  • Faculty and Year of Graduation: Uludağ University Faculty of Medicine, 2009
  • Year and Place of Specialization: Karadeniz Technical University Faculty of Medicine, Department of Internal Medicine, 2015
Experience:
  • 2016- 2018: Erbaa State Hospital (compulsory service)
  • 2018- 2020: Kütahya Evliya Çelebi Training and Research Hospital
  • 2020-2022: Haseki Training and Research Hospital
  • 2022-2024: Istanbul Oncology Hospital
  • 2024-present: Ulus Liv Hospital
  • The Effect of the Covid-19 Pandemic Process on Outpatient Clinic Applications of Diabetic Patients, University of Health Sciences 3rd Internal Medicine Congress SS-79 9-12 December 2020, Haydar Temizyürek, Şencay Yıldız Şahin
  • The Role of Helicobacter Pylori in the Epidemiology of Patients with Stomach Cancer, Health Sciences University 3rd Internal Medicine Congress SS-38 9-12 December 2020, Şencay Yıldız Şahin, Nazım Onur Şahin, Orhan Özgür
  • Carotid Intima Media Thickness in Metabolic Syndrome, 57th National Diabetes Congress SS-31 01-05 June 2021, Şencay Yıldız Şahin, Haydar Temizyürek, Saliha Özkabakçı
  • The Relationship Between Serum Uric Acid Level and COVID-19 Disease Severity, University of Health Sciences 4th Internal Medicine Congress SB-26 24-27 November 2021, Şencay Yıldız Şahin
  • Association Between Non-Alcoholic Fatty Liver Disease Fibrosis Scoring Systems With Micro And Macrovascular Complications, 57. European Association For The Study of Diabetes (EASD), 27 September- 1 October 2021, H. Ataoglu, Ş. Yıldız Şahin, S. Özkabakçı
  • The Relationship Between Body Mass Index Value and Liver Noninvasive Fibrosis Scores, 11th National Haseki Medical Congress, SS-010 2-5 September 2021, Şencay Yıldız Şahin, Saliha Özkabakçı
  • Thromboembolic events after COVID-19 in young people, 9th International Hippocratic Medicine and Health Sciences Congress, 09-10 October 2022, Şencay Yıldız Şahin, Şule Yuzbaoğlu
  • Markers of Non-alcoholic Fatty Liver Disease among Metabolically Healthy and Unhealthy Obese Individuals, Şencay Yıldız Şahin, Saliha Yusufoğlu, Sevim Özdemir, Mehmet Koçak, Hayriye Esra Ataoğlu, Bosphorus Med J, 2023;10(3):153–158 doi: 10.14744 /bmj.2023.24482
Book:
  • Endocrinology and Diabetes – Stephen M. Orme Ramzi Ajjan -01.01.2015, Editorial
  • Diabetes with Current Approaches – Current Approaches in the Pharmacological Treatment of Diabetes, 01.06.2022, Section Writing
  • Member, Turkish Medical Association 2022- Present
  • Member, Internal Medicine Specialization Education Research Association (IÇHASDER) 2022-Present
  • Member, TIHUD (Turkish Internal Medicine Specialization Association)
  • AkademiKA Basic Good Clinical Practices Training (07.12.2020-08.12.2020)
  • AkademiKA Advanced Good Clinical Practices Training (16.10.2021-17.10.2021)
  • 15th National Hypertension and Kidney Diseases Congress, Antalya, April, 2013
  • 20th National Internal Medicine Congress, Antalya, October, 2018
  • 41st Turkish Endocrine and Metabolic Diseases Congress, Antalya, April, 2019
  • 57th National Diabetes Congress, Bodrum, June 2021
  • 2nd Microbiota and Probiotic Microbiome Congress with International Participation, Istanbul, December, 2022
  • 4th Functional Medicine Congress, Sapanca, October, 2023
  • 44th Turkish Endocrine and Metabolic Diseases Congress, Istanbul, May, 2023
  • Integrative medicine treatments summit congress Istanbul, June, 2023
  • 3rd reinforcement summit congress, Antalya, February 2024

Ask Our Experts

Doctors

Maximum file size: 209.72MB

Subscribe to Liv E-newsletter